Evaluating the efficacy of dexamethasone in the treatment of patients with persistent acute respiratory distress syndrome: Study protocol for a randomized controlled trial

Trials

Volumn 17, Issue 1, 2016, Pages

  Villar, Jesús ^a,b,c   Belda, Javier ^d   Añón, José Manuel ^e   Blanco, Jesús ^a,f   Pérez Méndez, Lina ^a,g   Ferrando, Carlos ^d   Martínez, Domingo ^h   Soler, Juan Alfonso ⁱ   Ambrós, Alfonso ^j   Muñoz, Tomás ^k   Rivas, Rosana ^l   Corpas, Ruth ^m,u   Díaz Dominguez, Francisco J ⁿ   Soro, Marina ^d   García Bello, Miguel Angel ^b   Fernández, Rosa Lidia ^a,b   Kacmarek, Robert M ^o,p   Mosteiro, Fernando ^q   Díaz Lamas, Ana María ^q   Arrojo, Regina ^q   Ferreres, José ^d   Blanquer Olivas, José ^d   Chico, Mario ^r   Toral, Darío ^r   García Bello, Miguel Ángel ^b   Martín, Carmen ^j   del Campo, Rafael ^j   Carriedo, Demetrio ⁿ   Díaz, Francisco Javier ⁿ   González Luengo, Raúl Ismael ⁿ   Domínguez, Cristina ^s   Cariñena, Agustín ^s   álvarez, Julián ^s   Macías, Santiago ^t   Tallet, Alec ^t   Capilla, Lucía ⁱ   Pérez Mendez, Lina ^g   Alba, Francisco ^u   Romera, Miguel A ^v   Fernández, Lorena ^f   Prieto, Ana María ^f   Conesa, Luís A ^h   García, Manuel A ^h   González, Elena ^e   Solano, Rosario ^e   Cruz, María Mar ^w   Magro, María Ángela ^w   more..

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^e HOSPITAL VIRGEN DE LA LUZ   (Spain)

^f HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^g HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^h HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

ⁱ HOSPITAL MORALES MESEGUER   (Spain)

^j HOSPITAL GENERAL UNIVERSITARIO DE CIUDAD REAL   (Spain)

^k HOSPITAL DE CRUCES   (Spain)

^l HOSPITAL DE GALDAKAO   (Spain)

^m HOSPITAL NUESTRA SEÑORA DEL PRADO   (Spain)

ⁿ HOSPITAL DE LEÓN   (Spain)

^o MASSACHUSETTS GENERAL HOSPITAL   (United States)

^p HARVARD UNIVERSITY   (United States)

^q Hospital de A Coruña   (Spain)

^r HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^s HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^t HOSPITAL GENERAL DE SEGOVIA   (Spain)

^u Hospital NS del Prado   (Spain)

^v HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^w HOSPITAL VIRGEN DE LA SALUD   (Spain)

more..

Author keywords

Acute respiratory distress syndrome; Corticoids; Dexamethasone; Lung protective ventilation; Positive end expiratory pressure

Indexed keywords

DEXAMETHASONE; ANTIINFLAMMATORY AGENT;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; AGED; CLINICAL PROTOCOL; CLINICAL TRIAL; DOSE RESPONSE; HOSPITAL MORTALITY; KAPLAN MEIER METHOD; MIDDLE AGED; STATISTICAL BIAS; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; BIAS; CLINICAL PROTOCOLS; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; SAMPLE SIZE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84979211166     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-016-1456-4     Document Type: Article

References (39)

1. Villar J, Blanco J, Kacmarek RM. Acute respiratory distress syndrome definition: do we need a change? Curr Opin Crit Care. 2011;17:13-7.
2. Villar J, Blanco J, Añón JM, Santos-Bouza A, Blanch L, Ambrós A, Gandía F, Carriedo D, Mosteiro F, Basaldúa S, Fernández RL, Kacmarek RM. The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation. Intensive Care Med. 2011;7:1932-41.
3. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids - new mechanism for old drugs. N Engl J Med. 2005;353:1711-23.
4. Monton C, Ewig S, Torres A, El-Ebiary M, Filella X, Rañó A, Xaubet A. Role of glucocorticoids on inflammatory response in nonimmunosupressed patients with pneumonia: a pilot study. Eur Respir J. 1999;14:218-20.
5. Weigelt JA, Norcross JF, Borman KR, Snyder III WH. Early steroid therapy for respiratory failure. Arch Surg. 1985;120:536-40.
6. Luce JM, Montgomery AB, Marks JD, Turner J, Metz CA, Murray JF. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis. 1988;138:62-8.
7. Bone RC, Fisher Jr CJ, Clemmer TP, Slotman GJ, Metz CA. Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest. 1987;92:1032-6.
8. Bernard GR. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med. 1987;317:1565-70.
9. Hooper RG, Kearl RA. Established ARDS with a sustained course of adrenocortical steroids. Chest. 1990;97:138-43.
10. Meduri GU, Belenchia JM, Estes RJ, Wunderink RG, el Torky M, Leeper Jr KV. Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids. Chest. 1991;100:943-52.
11. Meduri GU, Chinn AJ, Leeper KV, Wunderink RG, Tolley E, Winer-Muram HT, Khare V, Eltorky M. Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Patterns of response and predictors of outcome. Chest. 1994;105:1516-27.
12. Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, Tolley EA. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1998;280:159-65.
13. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M, National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354:1671-84.
14. Annane D, Sebille V, Bellissant E. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med. 2006;34:22-30.
15. Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest. 2007;131:954-63.
16. Tang BM, Craig JC, Eslick GD, Seppelt I, McLean AS. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med. 2009;37:1594-603.
17. Annane D, Sebille V, Charpentier C, Bollaert PE, François B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troché G, Chaumet-Riffaud P, Bellissant E. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288:862-71.
18. Meijvis SC, Hardeman H, Remmelts HH, Heijligenberg R, Rijkers GT, van Velzen-Blad H, et al. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial. Lancet. 2011;377:2023-30.
19. Cicarelli DD, Vieira JE, Benseñor FE. Early dexamethasone treatment for septic shock patients: a prospective randomized clinical trial. Sao Paulo Med J. 2007;125:237-41.
20. de Gans J, van de Beek D, European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002;347:1549-56.
21. Azoulay E, Canet E, Raffoux E, Lengliné E, Lemiale V, Vincent F, et al. Dexamethasone in patients with acute lung injury from acute monocytic leukemia. Eur Respir J. 2012;39:648-53.
22. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, LeGall JR, Morris A, Spragg R, the Consensus Committee. The American-European Consensus Conference on ARDS. Am J Respir Crit Care Med. 1994;149(3 Part 1):818-24.
23. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307:2526-33.
24. Villar J, Pérez-Méndez L, López J, Belda J, Blanco J, Saralegui I, Suárez-Sipmann F, López J, Lubillo S, Kacmarek RM, HELP Network. An early PEEP/FIO2 trial identifies different degrees of lung injury in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2007;176:795-804.
25. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301-8.
26. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-29.
27. Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988;138:720-3.
28. Vincent JL, de Mendonça A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med. 1998;26:1793-800.
29. Villar J, Manzano JJ, Blazquez MA, Lubillo S, Villalobos J, Quintana J. Multiple system organ failure in acute respiratory failure. J Crit Care. 1991;6:75-80.
30. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31:1250-6.
31. Bell RC, Coalson JJ, Smith JD, Johanson Jr WG. Multiple organ system failure and infection in adult respiratory distress syndrome. Ann Intern Med. 1983;99:293-8.
32. Schoenfeld DA, Bernard GR, ARDS Network. Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med. 2002;30:1772-7.
33. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet. 1967;2:319-23.
34. Horita N, Hashimoto S, Miyazawa N, Fujita H, Kojima R, Inoue M, Ueda A, Ishigatsubo Y, Kaneko T. Impact of corticosteroids on mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis. Intern Med. 2015;54:1473-9.
35. Blum CA, Nigro N, Briel M, Schuetz P, Ullmer E, Suter-Widmer I, Winzeler B, Bingisser R, Elsaesser H, Drozdov D, Arici B, Urwyler SA, Refardt J, Tarr P, Wirz S, Thomann R, Baumgartner C, Duplain H, Burki D, Zimmerli W, Rodondi N, Mueller B, Christ-Crain M. Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2015;385:1511-8.
36. Maerz LL, Akhtar S. Perioperative glycemic management in 2011: paradigm shifts. Curr Opin Crit Care. 2011;17:370-5.
37. Shorr AF, Chan CM. Clinical trials in the critically ill: practical and ethical challenges: comment on "Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support". Arch Intern Med. 2011;171:1946-7.
38. Burnham EL, Janssen WJ, Riches DW, Moss M, Downey GP. The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance. Eur Respir J. 2014;43:276-85.
39. Meduri GU, Bridges L, Shih MC, Marik PE, Siemieniuk RA, Kocak M. Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med. 2016;42(5):829-40.